Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.

MLA

Cao, Chenyu, et al. “Nano Co-Delivery of Doxorubicin and Plumbagin Achieves Synergistic Chemotherapy of Hepatocellular Carcinoma.” International Journal of Pharmaceutics, vol. 661, Aug. 2024, p. 124424. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2024.124424.

APA

Cao, C., Li, Y., Shi, F., Jiang, S., Li, Y., Yang, L., Zhou, X., Gao, Y., Tang, F., Li, H., Han, S., Yu, Z., Zou, Y., & Guo, J. (2024). Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma. International Journal of Pharmaceutics, 661, 124424. https://doi.org/10.1016/j.ijpharm.2024.124424

Chicago

Cao, Chenyu, Yifei Li, Fangzhou Shi, Shanshan Jiang, Yutong Li, Leilei Yang, Xinyi Zhou, et al. 2024. “Nano Co-Delivery of Doxorubicin and Plumbagin Achieves Synergistic Chemotherapy of Hepatocellular Carcinoma.” International Journal of Pharmaceutics 661 (August): 124424. doi:10.1016/j.ijpharm.2024.124424.